Rayence Co., Ltd. (KOSDAQ:228850)
South Korea · Delayed Price · Currency is KRW 5,890.00
-690.00 (-10.49%)
At close: Aug 11, 2026
Rayence Market Cap
Rayence has a market cap or net worth of 93.63 billion as of August 12, 2026. Its market cap has decreased by -7.89% in one year.
Market Cap
93.63B
Enterprise Value
-51.80B
Revenue
124.23B
Ranking
n/a
PE Ratio
240.05
Stock Price
5,890.00
ChartMarket Cap Chart
Since April 11, 2016, Rayence's market cap has decreased from 382.42B to 93.63B, a decrease of -75.52%. That is a compound annual growth rate of -12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 93.63B | 14.42% |
| Dec 30, 2025 | 81.83B | -15.45% |
| Dec 30, 2024 | 96.78B | -34.22% |
| Dec 28, 2023 | 147.14B | -15.00% |
| Dec 29, 2022 | 173.10B | -10.20% |
| Dec 30, 2021 | 192.77B | 11.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foodnamoo. | 104.61B |
| CMG Pharmaceutical | 104.28B |
| DSK Co., Ltd. | 103.18B |
| Vaxcell-Bio Therapeutics | 103.15B |
| Sewoon Medical | 103.03B |
| HancomWITH | 102.97B |
| ONEUL E&M co.,Ltd. | 102.85B |
| LB Investment | 102.56B |